iRADIOLOGY

iRADIOLOGY is a peer-reviewed open access journal devoted to radiology and to the multidisciplinary research that turns imaging into precision medicine, and Wiley publishes it for Tsinghua University Press and the Affiliated Hospital of Guizhou Medical University. The first volume is dated 2023, the 2025 Journal Impact Factor is 2.4, and CiteScore is 1.2.《放射学（iRADIOLOGY）》是一本同行评审的开放获取期刊，专注放射学以及把影像转化为精准医学的跨学科研究，由 Wiley 为清华大学出版社与贵州医科大学附属医院出版。首卷年份为 2023 年，2025 年期刊影响因子为 2.4，CiteScore 为 1.2。

Scope

• The aims and scope page describes a journal that covers key topics in every branch of radiology and in the related multidisciplinary work where imaging techniques are developed and applied for precision medicine and precision health.宗旨与范围页把刊物描述为覆盖放射学各分支，以及影像技术为精准医学与精准健康而开发、应用的相关跨学科工作。

• That remit is set out as a platform for rapid academic exchange, one that reports the newest developments in these fields together with the directions they are likely to take.这一范围被表述为快速学术交流的平台，既报道上述领域的最新进展，也呈现它们可能延伸的方向。

• The letter i in the title stands for six commitments, and the page names them one by one as integration, innovation, insight, interdisciplinary, international and intelligence.刊名里的 i 代表六项承诺，页面逐条列出，即整合、创新、洞见、跨学科、国际化与智能。

• Integration means the journal breaks the boundaries between fields and joins radiology to pathology, genetics, engineering, chemistry and the other disciplines that now shape imaging science.整合意味着打破学科之间的边界，把放射学与病理学、遗传学、工程学、化学以及如今塑造影像科学的其他学科连接起来。

• Innovation is treated as the condition for radiology to keep thriving in the era of precision health, while insight stands for the understanding of disease that images bring to diagnosis and management.创新被视为放射学在精准健康时代持续兴旺的条件，洞见则指影像为疾病诊断与管理带来的认识。

• Interdisciplinary acknowledges the multidisciplinary character of the field, and international describes a journal that gathers imaging researchers from around the world into one editorial enterprise.跨学科承认这一领域固有的多学科性质，国际化则指一本把世界各地影像研究者汇聚到同一编辑事业中的期刊。

• Intelligence points to computer science and engineering, the two forces the editors credit with making radiology a smarter and more quantitative discipline.智能指向计算机科学与工程学，编辑部认为这两股力量让放射学变得更聪明、更定量。

• Biomedical imaging, functional imaging and molecular imaging form the first block of topics, with multimodality work running across X-ray, CT, MRI, ultrasound, SPECT, PET, optical imaging and photoacoustic imaging.生物医学影像、功能影像与分子影像构成第一组主题，多模态工作横跨 X 射线、CT、MRI、超声、SPECT、PET、光学成像与光声成像。

• Clinical radiology follows, and the page lists neuroradiology, head and neck radiology, thoracic radiology, breast radiology, abdominal radiology, musculoskeletal radiology, urogenital radiology, pediatric radiology and interventional radiology as its parts.临床放射学紧随其后，页面把神经影像、头颈影像、胸部影像、乳腺影像、腹部影像、骨骼肌肉影像、泌尿生殖影像、儿科影像与介入放射学列为它的组成部分。

• Molecular probes, theranostics, nanomedicine and biomaterials make up a third block, the place where chemistry and materials science meet the imaging clinic.分子探针、诊疗一体化、纳米医学与生物材料构成第三组，化学与材料学在这里与影像临床相遇。

• Image processing and visualization are named as a block of their own, covering reconstruction, segmentation, registration and the display methods that make a volume of image data legible.图像处理与可视化单列为一组，涵盖重建、分割、配准以及让整卷图像数据可读的显示方法。

• Computer technology in radiology closes the list, with AI assisted radiology, computer assisted diagnosis and radiation therapy named as the applications the editors expect to see.计算机技术在放射学中的应用为清单收尾，人工智能辅助放射学、计算机辅助诊断与放射治疗被点名为编辑部期待看到的应用。

• On the journal home page the same territory is organised into five academic sections, labelled Imaging modality, Clinical radiology, Molecular imaging, Image and data mining and Image artificial intelligence.在刊物首页，同一片领域被组织为五个学术版块，分别标注为影像模态、临床放射学、分子影像、影像与数据挖掘以及影像人工智能。

• The editors sum up the focus as basic, translational and clinical progress in functional and molecular imaging and in imaging based therapeutics, and they ask for original papers of high quality.编辑部把重点概括为功能与分子影像以及影像引导治疗在基础、转化与临床层面的进展，并征集高质量的原创论文。

History

• The first volume is dated 2023, the year the National Library of Medicine also records as the start of the title, and the launch joined a university press with a teaching hospital.第 1 卷标注为 2023 年，美国国家医学图书馆同样把这一年记作刊物的起始年，创刊由一家大学出版社与一家教学医院联手推动。

• Tsinghua University Press and the Affiliated Hospital of Guizhou Medical University host the journal, and the Chinese Society of Molecular Imaging, a branch of the Chinese Biophysical Society, counts it as an official publication.清华大学出版社与贵州医科大学附属医院共同主办该刊，中国生物物理学会分子影像学分会将它列为官方出版物。

• Wiley handles publication and distribution from Chichester, and its name appears on the imprint beside that of the university press which holds the title.Wiley 在奇切斯特承担出版与发行，其署名与拥有该刊的大学出版社并列出现在版本记录中。

• No earlier title or renaming appears in the publisher record or in the library catalogue, so the journal has carried the same name since the first volume.出版方记录与图书馆目录中都没有更早的题名或改名信息，刊物自第 1 卷起一直使用同一个名字。

• Volume 1 opened in the spring of 2023, with one review of molecular imaging for cancer immunotherapy in pages 3 to 17 and another on near infrared fluorescent probes in pages 36 to 60, both online in March.第 1 卷在 2023 年春季开局，第 3 至 17 页刊登癌症免疫治疗分子影像综述，第 36 至 60 页刊登近红外荧光探针综述，两篇都在 3 月上线。

• The National Library of Medicine dates the bimonthly rhythm from 2024, and volume 3 in 2025 carries six issues, opening in February and closing in December.美国国家医学图书馆把双月刊的节奏记在 2024 年起，2025 年的第 3 卷共 6 期，2 月开卷，12 月收尾。

• Volume numbers advance one a year, so volume 2 covers 2024, volume 3 covers 2025 and volume 4 covers 2026, whose fourth issue appeared in August.卷号每年递增一卷，第 2 卷对应 2024 年，第 3 卷对应 2025 年，第 4 卷对应 2026 年，其第 4 期在 8 月面世。

• Themed sections have run from early on, among them a December 2024 collection on innovation and application of artificial intelligence in radiology, edited by Guang Yang and Pinggui Lei.主题栏目很早就已出现，2024 年 12 月的一辑讨论人工智能在放射学中的创新与应用，由（Guang Yang）与（Pinggui Lei）担任客座编辑。

• A second themed section, on fetal imaging and maternal and children imaging, filled volume 3 issue 3 in June 2025 under guest editors Su-Zhen Dong, Liqun Sun and Lianxiang Xiao.另一辑主题栏目聚焦胎儿影像与母胎及儿童影像，2025 年 6 月占据第 3 卷第 3 期，客座编辑为（Su-Zhen Dong）、（Liqun Sun）与（Lianxiang Xiao）。

• The title entered the Emerging Sources Citation Index, while PubMed carries selected citations rather than the whole output, a distinction the library record states plainly.刊物进入新兴来源引文索引，PubMed 只收录部分文章的引文，并未覆盖全部产出，图书馆记录把这一区别写得很清楚。

• The first Journal Impact Factor, reported in the 2025 Journal Citation Reports, is 2.4, matching the five-year figure, and Clarivate placed the journal at 101 of 217 in radiology, nuclear medicine and medical imaging for Q2.首个期刊影响因子在 2025 年期刊引证报告中公布，数值为 2.4，与五年值相同，Clarivate 把该刊放在放射学、核医学与医学影像类 217 种期刊的第 101 位，属于 Q2。

• Open access has been the only route since launch, every article carries a gold licence, and article publication charges are waived at present, so an author pays nothing at acceptance.自创刊起只走开放获取路线，每篇文章都以金色许可发布，文章处理费目前免收，作者在录用环节无需付费。

• Output runs at about 25 articles a year, total citations sit near 206, and a cited half-life of 1.7 years marks a literature whose references cluster in very recent work.年发文约 25 篇，总被引接近 206 次，被引半衰期 1.7 年，说明这份文献的引用集中在很近期的成果上。

• The publisher reports an acceptance rate of 74 per cent and a median of 20 days from submission to first decision, numbers printed on the journal page beside CiteScore and the impact factor.出版方给出的接收率为 74%，投稿到首次决定的中位时间为 20 天，这两个数字与 CiteScore、影响因子并列印在刊物首页。

Editors

• Zhen Cheng, professor and director of the Molecular Imaging Center at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, holds the editor-in-chief post.主编（Zhen Cheng）是中国科学院上海药物研究所分子影像中心主任、教授。

• His research centres on molecular imaging probes and radiopharmaceuticals for the early detection and treatment of cancer, across PET, SPECT, optical, photoacoustic and MRI modalities, and his group has published more than 300 articles.他的研究围绕癌症早期发现与治疗所需的分子影像探针与放射性药物，横跨 PET、SPECT、光学、光声与 MRI 等模态，课题组已发表 300 余篇论文。

• Cheng worked at the Molecular Imaging Program of Stanford University from 2007 to 2021, first as assistant and then as associate professor, and he is a fellow of the Royal Society of Chemistry and of SPIE.2007 年至 2021 年，他在斯坦福大学分子影像项目工作，先任助理教授，后任副教授，并当选英国皇家化学会与 SPIE 会士。

• Haiyang Li of the Affiliated Hospital of Guizhou Medical University holds the honorary editor-in-chief title, Shi Zuo at the same hospital is co-editor-in-chief, and Bo Gao there is executive editor-in-chief.名誉主编（Haiyang Li）来自贵州医科大学附属医院，共同主编（Shi Zuo）与该院执行主编（Bo Gao）同样出自这家医院。

• Four associate editors divide the subject streams: Jong Seung Kim at Korea University in Seoul, Yubin Miao at the University of Colorado Denver, Xiuying Wang at the University of Sydney and Yun Zhou at ShanghaiTech University.四位副编辑分管学科流向，分别是首尔高丽大学的（Jong Seung Kim）、科罗拉多大学丹佛分校的（Yubin Miao）、悉尼大学的（Xiuying Wang）与上海科技大学的（Yun Zhou）。

• The editorial board lists 32 members, most of them in China, with the rest drawn from the United States, Korea and India, a roster with a national core and an international rim.编委会列出 32 位成员，多数在中国，其余来自美国、韩国与印度，名单因此呈现国内为主干、国际为外缘的结构。

• Chinese members include Shenghong Ju at Zhongda Hospital of Southeast University, Zaiyi Liu at Guangdong Provincial People's Hospital, Hairong Zheng at the Shenzhen Institutes of Advanced Technology and Xin Zhou at the Wuhan Institute of Physics and Mathematics.中国编委包括东南大学中大医院的（Shenghong Ju）、广东省人民医院的（Zaiyi Liu）、中国科学院深圳先进技术研究院的（Hairong Zheng）与中国科学院武汉物理与数学研究所的（Xin Zhou）。

• American seats cover City of Hope, Massachusetts General Hospital and Harvard Medical School, Stanford, Yale, the University of Southern California and the University of Missouri, while Jung-Joon Min represents Chonnam National University in Korea and Pritha Ray the Tata Memorial Center in India.美国席位覆盖希望之城、哈佛医学院麻省总医院、斯坦福大学、耶鲁大学、南加州大学与密苏里大学，韩国的（Jung-Joon Min）来自全南大学，印度的（Pritha Ray）来自塔塔纪念中心。

• An academic advisory board of five sits above the editors, with Min Chen of Beijing Hospital, Jiahong Dong of Tsinghua University, Gaojun Teng of Southeast University, Jie Tian of the Institute of Automation and Jinming Yu of Shandong University.编委会之上设五人学术顾问委员会，成员为北京医院的（Min Chen）、清华大学的（Jiahong Dong）、东南大学的（Gaojun Teng）、中国科学院自动化研究所的（Jie Tian）与山东大学的（Jinming Yu）。

• Review is single blind, as the author guidelines state, and a manuscript that clears the initial editorial check normally draws two or more external reports before an associate editor sums them up.作者指南写明评审采用单盲，通过初审的稿件通常至少获得两份外部审稿意见，再由副编辑汇总。

• The editor-in-chief assigns manuscripts to associate editors in sequence, each associate editor recruits the referees, and a decision usually follows within four weeks of receipt, with minor revisions due in two weeks and major revisions in three.主编按顺序把稿件分给副编辑，副编辑征集审稿人，决定一般在收稿后 4 周内作出，小修须在 2 周内返回，大修须在 3 周内完成。

• High priority papers can be fast tracked within a week, authors may name up to three international referees, and submissions enter through Free Format Submission at authors.wiley.com/journal/IRD3, with the office reachable at IRD3@wiley.com.高优先级稿件可在一周内快审，作者可推荐至多 3 位国际审稿人，投稿以免格式方式经 authors.wiley.com/journal/IRD3 提交，编辑部邮箱为 IRD3@wiley.com。

• Original Articles allow 3000 words, a 250 word structured abstract, eight figures and 50 references, while Reviews allow 6000 words, ten figures and 100 references, and a Case Image is one picture with 150 words, which the guidelines insist is not a case report.原创论文上限 3000 词，须附 250 词结构式摘要、8 幅图表与 50 条参考文献，综述放宽到 6000 词与 100 条参考文献，病例影像只有 1 幅图与 150 字说明，指南强调它并非病例报告。

• Editorials come by invitation only, Commentary and Short Communication are capped at 1500 words, Letters at 500, and the journal also takes Consensus papers, preprints, Refer and Transfer submissions and Registered Reports.社论只接受编辑部约稿，评论与短通讯以 1500 词为限，读者来信以 500 词为限，刊物同样接收共识文件、预印本、Refer & Transfer 转投稿件与注册报告。